Clinical Predictors of Fluoroquinolone‐Resistant <i>Escherichia coli</i> in Transrectal Ultrasound‐Guided Prostate Biopsy: Insights for Tailored Prophylaxis
Elevated C-reactive protein and immunosuppressive therapy are strong clinical predictors of fluoroquinolone-resistant E. coli colonization. These factors should be integrated into pre-biopsy assessment to guide selective rectal swab testing and tailor prophylactic strategies, thereby enhancing patient safety and reducing antibiotic resistance.
Authors
- Takatoshi Somoto
- Yuta Suzuki (ORCID: https://orcid.org/0000-0002-9406-4691)
- Naomi Shimizu (ORCID: https://orcid.org/0000-0001-5063-056X)
- Yuka Sugizaki
- Takahide Noro
- Ryo Oka (ORCID: https://orcid.org/0000-0003-1715-2222)
- Takanobu Utsumi (ORCID: https://orcid.org/0000-0002-9423-7361)
- Nobuyuki Hiruta (ORCID: https://orcid.org/0009-0008-9985-575X)
- Naoto Kamiya (ORCID: https://orcid.org/0000-0002-4183-2490)
- Shota Iijima
- Hiroyoshi Suzuki (ORCID: https://orcid.org/0000-0001-5838-114X)
- Takumi Endo
- Naoki Ishitsuka
Institutions
- Toho University (JP)
- Toho University Medical Center Sakura Hospital (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1111/iju.70082
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00